Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer

被引：0
|
作者：
Chikara Kunisaki
Masazumi Takahashi
Hirochika Makino
Takashi Oshima
Shoichi Fujii
Ryo Takagawa
Jun Kimura
Takashi Kosaka
Hidetaka A. Ono
Hirotoshi Akiyama
Kunio Kameda
Fumihiko Kito
Satoshi Morita
Itaru Endo
机构：
[1] Yokohama City University,Department of Surgery, Gastroenterological Center
[2] Yokohama Municipal Hospital,Department of Surgery
[3] Yokohama City University,Department of Gastroenterological Surgery
[4] Yokosuka Municipal Hospital,Department of Surgery
[5] Yokohama City University,Department of Clinical Statistics and Epidemiology
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 67卷
关键词：
Docetaxel; Gastric cancer; Phase II; S-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1363 / 1368
页数：5
相关论文
共 50 条
  • [1] Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer
    Kunisaki, Chikara
    Takahashi, Masazumi
    Makino, Hirochika
    Oshima, Takashi
    Fujii, Shoichi
    Takagawa, Ryo
    Kimura, Jun
    Kosaka, Takashi
    Ono, Hidetaka A.
    Akiyama, Hirotoshi
    Kameda, Kunio
    Kito, Fumihiko
    Morita, Satoshi
    Endo, Itaru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1363 - 1368
  • [2] Biweekly Docetaxel and S-1 Combination Chemotherapy as First-line Treatment for Elderly Patients with Advanced Gastric Cancer
    Kunisaki, Chikara
    Takahashi, Masazumi
    Ono, Hidetaka A.
    Hasegawa, Shinichi
    Tsuchida, Kazuhito
    Oshima, Takashi
    Ota, Mitsuyoshi
    Fukushima, Tadao
    Tokuhisa, Motohiko
    Izumisawa, Yusuice
    Takagawa, Ryo
    Kimura, Jun
    Kosaka, Takashi
    Makino, Hirochika
    Akiyama, Hirotoshi
    Endo, Itaru
    ANTICANCER RESEARCH, 2013, 33 (02) : 697 - 704
  • [3] Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer
    Quintero-Aldana, G.
    Jorge, M.
    Grande, C.
    Salgado, M.
    Gallardo, E.
    Varela, S.
    Lopez, C.
    Villanueva, M. J.
    Fernandez, A.
    Alvarez, E.
    Gonzalez, P.
    Castellanos, J.
    Casal, J.
    Lopez, R.
    Campos Balea, B.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (04) : 731 - 737
  • [4] Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer
    G. Quintero-Aldana
    M. Jorge
    C. Grande
    M. Salgado
    E. Gallardo
    S. Varela
    C. López
    M. J. Villanueva
    A. Fernández
    E. Alvarez
    P. González
    J. Castellanos
    J. Casal
    R. López
    B. Campos Balea
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 731 - 737
  • [5] Phase II study of biweekly docetaxel and cisplatin combination chemotherapy in first-line advanced gastric cancer
    Quintero, G., Sr.
    Jorge, M.
    Casal, J.
    Salgado, M.
    Candamio, S.
    Lopez, R.
    Mel, J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Phase I study of biweekly docetaxel and S-1 combination chemotherapy for advanced gastric cancer
    Kunisaki, Chikara
    Takahashi, Masazumi
    Nagahori, Yutaka
    Makino, Hirochika
    Takagawa, Ryo
    Sato, Tsutomu
    Oshima, Takashi
    Fujii, Shoichi
    Kosaka, Takashi
    Ono, Hidetaka A.
    Akiyama, Hirotoshi
    Shimada, Hiroshi
    ANTICANCER RESEARCH, 2008, 28 (4C) : 2473 - 2478
  • [7] A phase II study of biweekly oxaliplatin plus S-1 combination chemotherapy as a first-line treatment for patients with metastatic or advanced gastric cancer in China
    Xiao, Cheng
    Qian, Jiong
    Zheng, Yulong
    Song, Fang
    Wang, Qiangfeng
    Jiang, Haiping
    Mao, Chenyu
    Xu, Nong
    MEDICINE, 2019, 98 (20)
  • [8] Phase I study of S-1 and biweekly docetaxel combination chemotherapy for advanced and recurrent gastric cancer
    Takahashi, I
    Emi, Y
    Kakeji, Y
    Tokunaga, E
    Ushiro, S
    Oki, E
    Watanabe, M
    Baba, H
    Maehara, Y
    ONCOLOGY REPORTS, 2006, 15 (04) : 849 - 854
  • [9] A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer
    Haiping Jiang
    Jiong Qian
    Peng Zhao
    Xiaochen Zhang
    Yi Zheng
    Chenyu Mao
    Yulong Zheng
    Linghong Chen
    Yao Wang
    Haibo Mou
    Weijia Fang
    Lisong Teng
    Nong Xu
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 197 - 203
  • [10] A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer
    Jiang, Haiping
    Qian, Jiong
    Zhao, Peng
    Zhang, Xiaochen
    Zheng, Yi
    Mao, Chenyu
    Zheng, Yulong
    Chen, Linghong
    Wang, Yao
    Mou, Haibo
    Fang, Weijia
    Teng, Lisong
    Xu, Nong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (01) : 197 - 203
12345